GIP receptor shows surprising dual action: Both activation and blockade support weight loss

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that not only activate the GIP receptor (agonists) but also block it (antagonists). They also have a positive effect on body weight.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup